GlassScriptPhysician profile
Shivani Shah
NPI 1114587730
$2,606.92
in general payments reported to CMS, 2019-2025
11 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $152 · 2023: $1,256 · 2024: $679 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,133 · Education: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,132.53 |
| Education | $321.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $648.62 | 2022-2025 | Tremfya, Stelara |
| Janssen Scientific Affairs, LLC | $497.10 | 2023-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $389.28 | 2023-2024 | |
| Abbvie INC. | $267.33 | 2022-2025 | Rinvoq, Skyrizi |
| Amgen INC. | $213.72 | 2022-2025 | Krystexxa, Enbrel, Evenity |
| Ucb, INC. | $142.22 | 2022-2023 | |
| Horizon Therapeutics Plc | $132.67 | 2023 | Krystexxa |
| Fresenius Kabi USA, LLC | $104.28 | 2023 | Idacio |
| Lilly USA, LLC | $97.50 | 2023 | Taltz |
| Pfizer INC. | $78.24 | 2023 | |
| Radius Health, INC. | $35.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shivani Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.